SUS — Surgical Science Sweden AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK1.69bn
- SEK1.15bn
- SEK992.34m
Annual cashflow statement for Surgical Science Sweden AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 56.5 | 163 | 189 | 144 | 68.9 |
| Depreciation | |||||
| Non-Cash Items | -0.845 | -11.1 | 5.48 | 7.2 | 29.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -50.1 | -73.5 | -12 | -74.8 | -102 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 39.1 | 129 | 238 | 137 | 79.8 |
| Capital Expenditures | -14.4 | -34.5 | -44.1 | -47.5 | -49.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2,718 | 0 | — | — | -84.9 |
| Purchase of Investments | |||||
| Cash from Investing Activities | -2,733 | -34.5 | -44.1 | -47.5 | -134 |
| Financing Cash Flow Items | — | 12.2 | -2.04 | -5.53 | 0.048 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,922 | 17.1 | 15.8 | 228 | -260 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 230 | 117 | 201 | 334 | -352 |